The neutrophil to lymphocyte ratio (NLR) predicts adverse clinical outcomes in several cardiovascular diseases. Our aim was to investigate the association of residual SYNTAX score (rSS) with the NLR in patients (n = 613) with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. Patients were divided into 2 groups: group 1 with low NLR (<2.59) and group 2 with high NLR (>2.59). Coronary artery disease severity was calculated for both groups besides baseline clinical and demographic variables. Receiver operating characteristic curve analysis demonstrated that NLR with a cutoff value of 2.59 had good predictive value for increased rSS (area under the curve = 0.707, 95% CI: 0.661-0.752, P < .001). The median rSS value of group 2 was higher (2.0 [0-6.0]; 4.0 [0-10.0], P < .001) compared with group 1; the number of patients with high rSS was also higher in group 2 (26 [9.7%]; 107 [31.0%], P < .001). In multivariate logistic regression analysis, the NLR (odds ratio = 3.933; 95% CI: 2.419-6.393; P < .001) was an independent predictor of high rSS. Additionally, there was a positive correlation between NLR and rSS (r = 0.216, P < .001). In conclusion, higher NLR was an independent predictor of increased rSS in patients with STEMI.
MozaffarianDBenjaminEJGoAS, et al.Heart disease and stroke statistics-2016 update: a report from the American Heart Association American Heart Association. Circulation. 2016;133:447–54.
2.
TomaMBullerCEWesterhoutCM, et al.Non-culprit coronary artery percutaneous coronary intervention during acute ST segment elevation myocardial infarction: Insights from the APEX-AMI trial. Eur Heart J. 2010;31:1701–7.
3.
LeeJHParkHSChaeSC, et al.Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol. 2009;104:182–9.
4.
GenereuxPPalmeriniTCaixetaA, et al.Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: The residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol. 2012;59:2165–74.
5.
ManciniJHartiganPShawL, et al.Predicting outcome in the COURAGE trial (clinical outcomes utilizing revascularization and aggressive drug evalutation). JACC Cardiovasc Interv. 2014;7:195–201.
6.
LibbyPRidkerPMMaseriA. Inflammation and atherosclerosis. Circulation. 2002;105:1135–43.
7.
GulMUyarelHErgelenM, et al.Predictive value of neutrophil to lymphocyte ratio in clinical outcomes of non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Clin Appl Thromb Hemost. 2014;20:378–84.
8.
NunezJNunezEBodiV, et al.Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101:747–52.
9.
PapaAEmdinMPassinoCMichelassiCBattagliaDCocciF. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008;395:27–31.
10.
SahinDYElbasanZGürM, et al.Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction. Angiology. 2013;64:423–9.
11.
SianosGMorelMAKappeteinAP, et al.The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Euro Intervention. 2005;1(2):219–27.
12.
HorneBDAndersonJLJohnJM, et al.Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk?J Am Coll Cardiol. 2005;45:1638–43.
13.
ShenXHChenQShiYLiHW. Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Chin Med J. 2010;123:3438–43.
14.
HansenPR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 1995;91:1872–85.
15.
MehtaJDinermanJMehtaP, et al.Neutrophil function in ischemic heart disease. Circulation. 1989;79:549–56.
16.
SawantACAdhikariPNarraSR, et al.Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J. 2014;21:500–8.
17.
GibsonPHCuthbertsonBHCroalBL, et al.Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010;105:186–91.
18.
MaxwellSRLipGY. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol. 1997;58:95–117.
19.
KawaguchiHMoriTKawanoTKonoSSasakiJArakawaK. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J. 1996;132:9–12.
20.
HotchkissRSKarlIE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–50.
21.
BlumASclarovskySRehaviaEShohatB. Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J. 1994;127:1226–30.
22.
AzabBZaherMWeiserbsKF, et al.Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106:470–6.
23.
KayaMGAkpekMLamYY, et al.Prognostic value of neutrophil/ lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. Int J Cardiol. 2013;168:1154–9.
24.
SonmezOErtasGBacaksizA, et al.Relation of neutrophil-to-lymphocyte ratio with the presence and complexity of coronary artery disease: an observational study. Anadolu Kardiyol Derg. 2013;13:662–7.
25.
LoutfiMAyadSSobhyM. Impact of the Residual SYNTAX Score on Outcomes of Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease. Clin Med Insights Cardiol. 2016;10:29–35.
26.
RydenLGrantPJAnkerSD, et al.Task Force on diabetes p-d, cardiovascular diseases of the European Society of C, European Association for the Study of D, ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD-summary. Diabetes Vasc Dis Res. 2014;11:133–73.
27.
NataliAVichiSLandiPSeveriSL’AbbateAFerranniniE. Coronary Atherosclerosis in Type II Diabetes: Angiographic Findings and Clinical Outcome. Diabetologia. 2000;43:632–41.
28.
MertogluCGunayM. Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as Useful Predictive Markers of Prediabetes and Diabetes Mellitus. Diabetes Metab Syndr. 2017;11:127–31.
29.
RobertsWCShiraniJ. Comparison of cardiac findings at necropsy in octogenarians, nonagenarians, and centenarians. Am J Cardiol. 1998;82:627-31.
30.
KannelWB. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol. 2002;11:101–7.
31.
FihnSDGardinJMAbramsJ, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:44–164.
32.
LiJChenQLuoX, et al.Neutrophil-to-Lymphocyte Ratio Positively Correlates to Age in Healthy Population. J Clin Lab Anal. 2015;29:437–43.
33.
SqueriAGaibazziNReverberiCCaraccioloMMArdissinoDGherliT. Ejection fraction change and coronary artery disease severity: a vasodilator contrast stress-echocardiography study. J Am Soc Echocardiogr. 2012;25:454–9.
34.
DoğduOAkpekMYarlıoğlueşM, et al.Relationship Between Hematologic Parameters and Left Ventricular Systolic Dysfunction in Stable Patients With Multi-Vessel Coronary Artery Disease. Turk Kardiyol Dern Ars. 2012;40:706–13.
